Name: Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors (Video) | JoVE Journal
Uploaded: 2025-06-27T12:30:00.000+00:00
Duration: 5 min 46 s
Description: Learn a fluorescence-based assay to detect FEN1 nuclease activity and screen small-molecule inhibitors for cancer therapy research. This method offers a safer, efficient alternative to traditional techniques.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by the Jiangsu Higher Education Institution Innovative Research Team for Science and Technology (2021), Program of Jiangsu Vocational College Engineering Technology Research Center (2023), Key Technology Programme of Suzhou People&#39;s Livelihood Technology Projects (SYWD2024099), Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University (GZK12023013), Programs of the Suzhou Vocational Health College (SZWZYTD202201, SZWZYTD202205), and Qing-Lan Project of Jiangsu Province in China (2021, 2022).

The reagents and the equipment used in this study are listed in the Table of Materials.
1. FEN1 protein expression purification
<ol>
	<li>Protein purification
	<ol>
		<li>Remove the bacterial stock containing the target plasmid (see Table of Materials) from &#8722;80&#8239;&#176;C. Thaw at room temperature and inoculate 200&#8239;&#181;L from the frozen 1.5&#8239;mL microcentrifuge tubes into 20&#8239;mL LB medium containing 50&#8239;&#181;g/mL kanamycin using a 200&#8239;&#181;L pipette tip. 
		NOTE: The strain is E. coli BL21(DE3)-FEN1.</li>
		<li>Incubate at 37&#8239;&#176;C with shaking at 160&#8239;rpm for 12 h.</li>
		<li>Transfer the bacterial suspension into a 200&#8239;mL Erlenmeyer flask containing LB medium supplemented with 50&#8239;&#181;g/mL kanamycin. Continue incubation at 37&#8239;&#176;C with shaking at 160&#8239;rpm for 2-3 h.</li>
		<li>When the OD600 of the culture reaches approximately 0.6, add 2&#8239;mL of IPTG (final concentration: 1&#8239;mM). Continue incubation at 25&#8239;&#176;C, 160&#8239;rpm for 10 h.</li>
		<li>Transfer the induced culture to a pre-weighed 50&#8239;mL centrifuge tube. Centrifuge at 4&#8239;&#176;C and 2500&#8239;&#215;&#8239;g for 15 min. Discard the supernatant. Weigh the pellet-containing tube and subtract the weight of the empty tube to calculate the pellet mass.</li>
		<li>Add 7&#8239;mL of lysis buffer per gram of wet cell pellet. Use a pipette to resuspend the pellet thoroughly by pipetting up and down. 
		NOTE: Lysis buffer (10&#8239;mL total) contains 20&#8239;mM of Tris-HCl, 250&#8239;mM of NaCl, 2% Triton X-100, and ddH2O. Perform this step in a fume hood to ensure safe handling of chemical reagents.</li>
		<li>Transfer the bacterial suspension in lysis buffer to a &#8722;80&#8239;&#176;C freezer and freeze overnight. On the following day, thaw the suspension on a 4&#8239;&#176;C shaker for 1 h to enhance lysis efficiency.</li>
		<li>Lyse cells using ultrasound at 75% power for 45 min. Centrifuge the lysate at 12,000&#8239;&#215;&#8239;g for 20 min at 4&#8239;&#176;C to separate the supernatant from the pellet. 
		NOTE: If the lysate remains turbid, increase the volume of the lysis buffer or repeat freeze-thaw cycles. A nuclease inhibitor may also be added to preserve protein integrity and prevent degradation.</li>
		<li>Apply the clarified supernatant along the wall of a tube containing prepared protein purification resin. Wash with 10&#8239;mL of elution buffer to remove non-specifically bound proteins. 
		NOTE: Elution buffer contains 20&#8239;mM of Tris-HCl (pH 7.5), 250&#8239;mM of NaCl, 2% Triton X-100, 200&#8239;mM of imidazole, and distilled water.</li>
		<li>Elute the FEN1 protein by adding 5&#8239;mL of elution buffer along the inner wall of the tube.</li>
	</ol>
	</li>
	<li>Identification of target proteins by rapid coomassie brilliant blue staining
	<ol>
		<li>Prepare SDS-PAGE gels using 12% separating gel and 5% stacking gel according to the expected size of FEN1.</li>
		<li>Mix the target protein sample and BSA standard with 5&#215; sample buffer at a 1:4 ratio. Heat the mixture at 95&#8239;&#176;C for 5 min to fully denature the proteins.</li>
		<li>Load 20&#8239;&#181;L each of the BSA standard and denatured protein samples into separate wells of the SDS-PAGE gel.</li>
		<li>Connect the electrophoresis apparatus. Set the voltage to 90&#8239;V and run for 1 h and 40 min.</li>
		<li>After electrophoresis, transfer the gel to a staining container. Rinse with deionized water, then add 30&#8239;mL of protein staining solution and stain for 25 min. Recover the staining solution, rinse the gel with 20&#8239;mL of deionized water, and decolorize overnight on a horizontal shaker.</li>
		<li>After decolorization, place the gel on a transparent plastic plate and observe the protein bands under white light. 
		NOTE: If the bands are faint or protein concentration is low, concentrate the sample using ultrafiltration tubes. This step removes excess solvent and small molecules, improving protein concentration and ensuring accurate analysis in subsequent experiments.</li>
	</ol>
	</li>
</ol>
2. FEN1 TAMRA-labeled DNA substrate preparation
<ol>
	<li>TAMRA-labeled DNA substrate preparation
	<ol>
		<li>Design DNA oligonucleotide strands based on the specific cleavage activity of FEN1, referring to published methods17(see Table 1). The 5&#8242; end of the D1 sequence is modified with a fluorescent TAMRA label.</li>
		<li>Add mixed single-stranded DNA oligonucleotides to 10 &#956;L of annealing buffer in the following volumes: 5 &#956;L of D1 (10 pmol/&#956;L), 10 &#956;L of T1 (10 pmol/&#956;L), and 7.5 &#956;L of U2 (10 pmol/&#956;L). Add deionized water to bring the total volume to 50 &#956;L. 
		NOTE: The annealing buffer contains 100&#8239;mM of Tris-HCl (pH 7.5) and 10&#8239;mM of MgCl2.</li>
		<li>Heat the reaction mixture in a metal bath at 100&#8239;&#176;C for 1 min, then immediately transfer it to 72&#8239;&#176;C for 10 min18. 
		NOTE: The final DNA substrate is 80 nucleotides in length. The high initial temperature (100&#8239;&#176;C) ensures denaturation, while the annealing temperature (72&#8239;&#176;C) promotes accurate strand pairing.</li>
		<li>Turn off the heat source and allow the solution to cool gradually to room temperature, forming the complete double-stranded DNA substrate.</li>
	</ol>
	</li>
	<li>TAMRA-labeled DNA substrate assay
	<ol>
		<li>Prepare a 12% denaturing polyacrylamide gel by mixing 4.8&#8239;mL of 30% acrylamide (29:1), 4.32&#8239;mL of 6&#8239;M urea, 2.4&#8239;mL of 5&#215;&#8239;TBE, 50&#8239;&#181;L of 10% APS, 5&#8239;&#181;L of TEMED, and 0.48&#8239;mL of deionized water. Mix thoroughly to prepare the gel.</li>
		<li>Place the gel in a 37&#8239;&#176;C oven for 30 min to solidify.</li>
		<li>For detection, pipette 2&#8239;&#181;L of the synthesized DNA substrate into 18&#8239;&#181;L of distilled water and add 7.7&#8239;&#181;L Stop Buffer.</li>
		<li>For reference, pipette 2&#8239;&#181;L of TAMRA-labeled D1 into 18&#8239;&#181;L of distilled water and add 7.7&#8239;&#181;L of Stop Buffer.</li>
		<li>Load 20&#8239;&#181;L of each prepared sample onto the gel and perform SDS-PAGE electrophoresis to analyze DNA substrate formation.</li>
	</ol>
	</li>
</ol>
3. FEN1 nuclease activity assay
<ol>
	<li>FEN1 enzyme activity assay
	<ol>
		<li>Prepare 20&#8239;&#181;L of reaction mixture by combining 2&#8239;&#181;L of DNA substrate with FEN1 nuclease in the reaction buffer. 
		NOTE: The reaction buffer consists of 100&#8239;mM of Tris-HCl (pH 7.5), 200&#8239;mM of MgCl2, 2&#8239;mM of DTT, 0.2&#8239;mg/mL BSA, and deionized water.</li>
		<li>Incubate the reaction mixture at 37&#8239;&#176;C in a metal bath for 15 min.</li>
		<li>Terminate the reaction by adding 20&#8239;&#181;L of 2&#215; termination buffer.</li>
		<li>Load 20&#8239;&#181;L of the reacted sample onto a pre-prepared 12% denaturing polyacrylamide gel and perform electrophoresis at 100&#8239;V for 60 min.</li>
		<li>After electrophoresis, visualize the results using a fluorescence imaging system (600 pathway).</li>
	</ol>
	</li>
</ol>
4. Screening of small molecule inhibitors of FEN1 nuclease
<ol>
	<li>Small molecule inhibitor screening
	<ol>
		<li>Use a pipette to transfer 2&#8239;&#181;L of dimethyl sulfoxide (DMSO) into a 1.5&#8239;mL microcentrifuge tube.</li>
		<li>Add 2&#8239;&#181;L of FEN1 nuclease and 10&#8239;&#181;L of 2&#215; reaction buffer to the tube.</li>
		<li>Mix thoroughly and incubate the mixture on ice for 10 min.</li>
		<li>Add 2 &#956;L of DNA substrate and 4 &#956;L of deionized water, mix thoroughly to bring the total reaction volume to 20 &#956;L.</li>
		<li>Prepare a working dilution of the FEN1 nuclease inhibitor, FEN1-IN-4, by performing a two-fold serial dilution of a 1&#8239;M stock solution in DMSO.</li>
		<li>Pipette 2&#8239;&#181;L of FEN1 nuclease (0.03&#8239;&#181;g/&#181;L) and 2&#8239;&#181;L of the diluted FEN1-IN-4 inhibitor into a new 1.5&#8239;mL microcentrifuge tube. Add 10&#8239;&#181;L of 2&#215; reaction buffer and 4&#8239;&#181;L of deionized water. Mix gently and incubate on ice for 10 min to ensure sufficient interaction between the inhibitor and enzyme.</li>
		<li>Add 2&#8239;&#181;L of DNA substrate to the tube to form a final 20&#8239;&#181;L reaction mixture.</li>
		<li>Incubate the reaction at 37&#8239;&#176;C in a metal bath for 15 min.</li>
		<li>Terminate the reaction by adding 20&#8239;&#181;L of 2&#215; termination buffer.</li>
	</ol>
	</li>
</ol>
5. Evaluation of inhibitory potency of FEN1--IN-4 small molecule inhibitor
<ol>
	<li>Use a micropipette to take up 10 &#181;L of 2&#215; reaction buffer and add it to a 1.5 mL microcentrifuge tube.</li>
	<li>Add 2 &#181;L of FEN1 nuclease at a concentration of 0.03 &#181;g/&#181;L, as well as 2 &#181;L of FEN1 inhibitor FEN1-IN-4 at different concentration. 
	NOTE: Multiple concentration gradients should be established according to experimental requirements.</li>
	<li>Add 4 &#956;L of deionized water and mix the solution thoroughly. Place the 1.5 mL microcentrifuge tube on ice and incubate for 10 min.</li>
	<li>Add 2 &#181;L of double-stranded DNA substrate to the tube to form a 20 &#181;L reaction system.</li>
	<li>Place the EP tube in a 37&#8239;&#176;C metal bath for 15 min.</li>
	<li>After the reaction is complete, add 20 &#181;L of 2&#215; stop buffer to the reaction mixture to terminate the reaction.</li>
	<li>Observe the results using a fluorescence imaging device and plot the IC50&#160;curve19. 
	NOTE: Fluorescence intensity quantification was performed using Fiji/ImageJ20, followed by statistical analysis and visualization with graphing and analysis software21.</li>
</ol>

<ol><li>Xu, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Novel+cell-virus-virophage+tripartite+infection+systems+discovered+in+the+freshwater+lake+Dishui+Lake+in+Shanghai%2C+China%5BTitle%5D)+AND+%22J+Virol%22%5BJournal%5D)">Novel cell-virus-virophage tripartite infection systems discovered in the freshwater lake Dishui Lake in Shanghai, China.</a> J Virol. 94 (11), e00149(2020).</li>
<li>Mougari, S., Sahmi-Bounsiar, D., Levasseur, A., Colson, P., La Scola, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Virophages+of+giant+viruses%3A+An+update+at+eleven%5BTitle%5D)+AND+%22Viruses%22%5BJournal%5D)">Virophages of giant viruses: An update at eleven.</a> Viruses. 11 (8), 733(2019).</li>
<li>Paez-Espino, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diversity%2C+evolution%2C+and+classification+of+virophages+uncovered+through+global+metagenomics%5BTitle%5D)+AND+%22Microbiome%22%5BJournal%5D)">Diversity, evolution, and classification of virophages uncovered through global metagenomics.</a> Microbiome. 7 (1), 157(2019).</li>
<li>Zheng, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Functional+regulation+of+FEN1+nuclease+and+its+link+to+cancer%5BTitle%5D)+AND+%22Nucleic+Acids+Res%22%5BJournal%5D)">Functional regulation of FEN1 nuclease and its link to cancer.</a> Nucleic Acids Res. 39 (3), 781-794 (2011).</li>
<li>Yang, F., Hu, Z., Guo, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Small-molecule+inhibitors+targeting+FEN1+for+cancer+therapy%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">Small-molecule inhibitors targeting FEN1 for cancer therapy.</a> Biomolecules. 12 (7), 946(2022).</li>
<li>Wang, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inhibition+of+FEN1+promotes+DNA+damage+and+enhances+chemotherapeutic+response+in+prostate+cancer+cells%5BTitle%5D)+AND+%22Med+Oncol%22%5BJournal%5D)">Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.</a> Med Oncol. 40 (8), 242(2023).</li>
<li>Abdel-Fatah, T. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Genomic+and+protein+expression+analysis+reveals+flap+endonuclease+1+%28FEN1%29+as+a+key+biomarker+in+breast+and+ovarian+cancer%5BTitle%5D)+AND+%22Mol+Oncol%22%5BJournal%5D)">Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.</a> Mol Oncol. 8 (7), 1326-1338 (2014).</li>
<li>Guo, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((FEN1+endonuclease+as+a+therapeutic+target+for+human+cancers+with+defects+in+homologous+recombination%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+U+S+A%22%5BJournal%5D)">FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.</a> Proc Natl Acad Sci U S A. 117 (32), 19415-19424 (2020).</li>
<li>Zhao, E., Zhou, C., Chen, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Flap+endonuclease+1+%28FEN1%29+as+a+novel+diagnostic+and+prognostic+biomarker+for+gastric+cancer%5BTitle%5D)+AND+%22Clin+Res+Hepatol+Gastroenterol%22%5BJournal%5D)">Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.</a> Clin Res Hepatol Gastroenterol. 45 (1), 101455(2021).</li>
<li>Finger, L. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+3%27-flap+pocket+of+human+flap+endonuclease+1+is+critical+for+substrate+binding+and+catalysis%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">The 3'-flap pocket of human flap endonuclease 1 is critical for substrate binding and catalysis.</a> J Biol Chem. 284 (33), 22184-22194 (2009).</li>
<li>Liu, R., Qiu, J., Finger, L. D., Zheng, L., Shen, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+DNA-protein+interaction+modes+of+FEN-1+with+gap+substrates+and+their+implication+in+preventing+duplication+mutations%5BTitle%5D)+AND+%22Nucleic+Acids+Res%22%5BJournal%5D)">The DNA-protein interaction modes of FEN-1 with gap substrates and their implication in preventing duplication mutations.</a> Nucleic Acids Res. 34 (6), 1772-1784 (2006).</li>
<li>McWhirter, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Development+of+a+high-throughput+fluorescence+polarization+DNA+cleavage+assay+for+the+identification+of+FEN1+inhibitors%5BTitle%5D)+AND+%22J+Biomol+Screen%22%5BJournal%5D)">Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.</a> J Biomol Screen. 18 (5), 567-575 (2013).</li>
<li>Dorjsuren, D., Kim, D., Maloney, D. J., Wilson, D. M. 3rd, Simeonov, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Complementary+non-radioactive+assays+for+investigation+of+human+flap+endonuclease+1+activity%5BTitle%5D)+AND+%22Nucleic+Acids+Res%22%5BJournal%5D)">Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity.</a> Nucleic Acids Res. 39 (2), e11(2011).</li>
<li>Van Pel, D. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+evolutionarily+conserved+synthetic+lethal+interaction+network+identifies+FEN1+as+a+broad-spectrum+target+for+anticancer+therapeutic+development%5BTitle%5D)+AND+%22PLoS+Genet%22%5BJournal%5D)">An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development.</a> PLoS Genet. 9 (1), e1003254(2013).</li>
<li>Tumey, L. N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+identification+and+optimization+of+a+N-hydroxy+urea+series+of+flap+endonuclease+1+inhibitors%5BTitle%5D)+AND+%22Bioorg+Med+Chem+Lett%22%5BJournal%5D)">The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.</a> Bioorg Med Chem Lett. 15 (2), 277-281 (2005).</li>
<li>Tang, Y., Wei, W., Liu, Y., Liu, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fluorescent+assay+of+FEN1+activity+with+nicking+enzyme-assisted+signal+amplification+based+on+ZIF-8+for+imaging+in+living+cells%5BTitle%5D)+AND+%22Anal+Chem%22%5BJournal%5D)">Fluorescent assay of FEN1 activity with nicking enzyme-assisted signal amplification based on ZIF-8 for imaging in living cells.</a> Anal Chem. 93 (11), 4960-4966 (2021).</li>
<li>Liu, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((fragment+maturation+involves+%CE%B1-segment+error+editing+by+the+mammalian+FEN1%2FMutS%CE%B1+functional+complex%5BTitle%5D)+AND+%22EMBO+J%22%5BJournal%5D)">fragment maturation involves α-segment error editing by the mammalian FEN1/MutSα functional complex.</a> EMBO J. 34 (13), 1829-1843 (2015).</li>
<li>Zheng, L., Dai, H., Qiu, J., Huang, Q., Shen, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Disruption+of+the+FEN-1%2FPCNA+interaction+results+in+DNA+replication+defects%2C+pulmonary+hypoplasia%2C+pancytopenia%2C+and+newborn+lethality+in+mice%5BTitle%5D)+AND+%22Mol+Cell+Biol%22%5BJournal%5D)">Disruption of the FEN-1/PCNA interaction results in DNA replication defects, pulmonary hypoplasia, pancytopenia, and newborn lethality in mice.</a> Mol Cell Biol. 27 (8), 3176-3186 (2007).</li>
<li>Hilda, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Alginate-based+3D+cell+culture+technique+to+evaluate+the+half-maximal+inhibitory+concentration%3A+An+in+vitro+model+of+anticancer+drug+study+for+anaplastic+thyroid+carcinoma%5BTitle%5D)+AND+%22Thyroid+Res%22%5BJournal%5D)">Alginate-based 3D cell culture technique to evaluate the half-maximal inhibitory concentration: An in vitro model of anticancer drug study for anaplastic thyroid carcinoma.</a> Thyroid Res. 14 (1), 10(2021).</li>
<li>Nadine, S. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=%22Microstructure+analysis+of+polymer+amended+fluid+fine+tailings+using+Fiji-ImageJ+image+analysis+software%22">Microstructure analysis of polymer amended fluid fine tailings using Fiji-ImageJ image analysis software</a>. , Carleton University Theses and Dissertations. (2022).</li>
<li>Pablo, T. Quantifications figures 2-6 & supplemental fig. 1 (GraphPad Prism 8.1 files). <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aPablo%2C+T+%22Figshare%22">Figshare</a>. , (2019).</li>
</ol>

The authors have no conflicts of interest to disclose.

The FEN1 nuclease activity assay and small molecule inhibitor screening are central to research on DNA damage repair and cancer development. Compared to traditional radiolabeling techniques, the present method offers a cost-effective, efficient, easy-to-operate, and safer alternative. Additionally, unlike fluorescence burst-based FEN1 assays, this approach provides a more intuitive visualization of substrate cleavage, thereby allowing a more accurate assessment of enzyme activity and offering a more reliable platform for...

DNA replication is not always flawless and can be disrupted by both internal and external factors. Consequently, the mechanisms of DNA replication and damage repair are vital for cell survival and genome stability. In this process, the human branching structure-specific endonuclease FEN1 (Flap Endonuclease 1), a core DNA nuclease, plays a crucial role1,2,3.
FEN1 is primarily involved in DNA replication and is indispensable for the maturation of Okazaki fragments on the lagging strand4,5. This ensures the efficient progression of DNA replication and the accurate repair of damaged DNA. However, abnormal increases in FEN1 levels have been closely linked to the development of various cancers6,7, such as lung and breast cancer7. Thus, FEN1 is not only essential for DNA replication and repair but has also garnered significant attention as a biomarker for cancer diagnosis and a potential therapeutic target8,9. The detection of FEN1 activity is essential for the early diagnosis of cancers and for advancing research on targeted therapies.
Given the importance of FEN1, and the need to study its activity for early cancer diagnosis and targeted therapy development, the primary goal of the method developed in this experiment was to accurately and efficiently measure FEN1 nuclease activity. This method aims to provide a reliable platform for screening small-molecule inhibitors targeting FEN1. By achieving these goals, the study seeks to contribute to a better understanding of FEN1&#39;s role in cancer and to facilitate the discovery of novel therapeutic strategies.
Numerous techniques exist for detecting FEN1 nuclease activity, each with distinct characteristics, principles, advantages, limitations, and applicable scenarios. For instance, gel electrophoresis and HPLC-based substrate separation methods provide intuitive results but involve cumbersome procedures and low throughput10,11. Fluorescence polarization (FP) assays face challenges in evaluating FEN1 activity due to interference from compound autofluorescence or light scattering, which affects FP signals. Although counter-screening strategies can partially exclude false positives, approximately 15% of primary active compounds are still misidentified due to technical interference12. The combined use of fluorescence donor/quencher pairs (e.g., TAMRA/BHQ-2) and AlphaScreen chemiluminescence presents drawbacks, such as the high synthesis cost of complex triple-flap fluorescent substrates, particularly limiting their utility in large-scale screening. Furthermore, the dual-flap structure of substrates may impede optimal binding with FEN1, reducing enzymatic cleavage efficiency and compromising detection sensitivity. Additionally, this approach heavily relies on specialized instruments (e.g., ViewLux, EnVision), restricting its adoption in resource-limited laboratories13,14,15. Fluorescent detection methods based on dual-flap dumbbell-shaped DNA nanoprobes functionalized with silver nanoclusters (DNA-AgNCs) suffer from batch-to-batch variability due to their dependence on precise annealing and in situ nucleation steps, hindering reproducibility and scalability. High costs and lengthy procedures further limit their practical application16.
In this article, a fluorescence labeling-based assay is developed to address current technical limitations and meet the growing demand for safer, user-accessible methods for studying FEN1 activity. This technique takes advantage of the specificity and high sensitivity of fluorescence detection, as well as the ability to engineer DNA substrates with defined structures that can be recognized and cleaved by FEN1 (Figure 1). This method streamlines experimental procedures while maintaining high accuracy in assessing FEN1 nuclease activity. Compared with traditional gel electrophoresis and HPLC-based techniques, it offers simplified operation and faster turnaround. Unlike fluorescence polarization assays, this approach enables rapid qualitative screening of compounds, establishing an efficient strategy for preliminary enzymatic evaluation.
This method is suitable for studying FEN1 nuclease activity in laboratory settings where access to radioactive materials is limited. It is also well-suited for screening a large number of small-molecule inhibitors in a relatively short time, especially when high sensitivity and specificity are required. However, it is not ideal for studies requiring absolute quantification with very high precision or for laboratories lacking basic fluorescence detection equipment and expertise in fluorescence signal analysis. For studies focusing on in vivo applications-where FEN1 behavior may be influenced by complex biological factors not replicated in current in vitro assay designs-further refinement or alternative methods may be necessary.
This fluorescence assay is highly sensitive and specific, providing a safe, convenient, and effective tool for studying FEN1 activity and developing its inhibitors.

<table><tbody><tr><td>1 M Tris-HCL</td><td>Beyotime</td><td>ST774</td><td></td></tr><tr><td>30% Acr-Bis (29:1)</td><td>Beyotime</td><td>ST003-500ml</td><td></td></tr><tr><td>5M Nacl</td><td>Beyotime</td><td>ST347</td><td></td></tr><tr><td>BeyoBlue Plus</td><td>Beyotime</td><td>P0003S</td><td></td></tr><tr><td>BL21(DE3)-FEN1</td><td>Vazyme</td><td>C504-F1</td><td></td></tr><tr><td>BSA</td><td>Beyotime</td><td>P0007</td><td></td></tr><tr><td>Decoloring shaker</td><td>Kylin-Bell</td><td>TS-100</td><td></td></tr><tr><td>DL-Dithiothreitol</td><td>Beyotime</td><td>ST041</td><td></td></tr><tr><td>Dry Bath Incubator</td><td>RUICHENG</td><td>DH200</td><td></td></tr><tr><td>Electrophoresis apparatus</td><td>Bei jing Liuyi Biotechnology</td><td>DDY-6D</td><td></td></tr><tr><td>FEN1-IN-4</td><td>TargetMOL</td><td>T8545</td><td></td></tr><tr><td>IPTG</td><td>Takaba</td><td>9030</td><td></td></tr><tr><td>Kanamycin Slufate</td><td>Biosharp</td><td>BS152</td><td></td></tr><tr><td>Laboratory Centrifuge</td><td>Thermo</td><td>SL 16R</td><td></td></tr><tr><td>LB Broth</td><td>Solarbio</td><td>L8291</td><td></td></tr><tr><td>Ni-NTA His Bind Resin</td><td>7se biotech</td><td>PANF001-001C</td><td></td></tr><tr><td>Odyssey FC</td><td>ODYSSEY</td><td>LI-COR</td><td></td></tr><tr><td>SDS-PAGE</td><td>Beyotime</td><td>P0015L</td><td></td></tr><tr><td>Trition-x-100</td><td>Shyuanye</td><td>S15022</td><td></td></tr></tbody></table>

fluorescence-based detection of fen1 nuclease activity and screening of small-molecule inhibitors

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

FEN1 (Flap Endonuclease 1) is a key DNA nuclease involved in DNA replication and damage repair, playing a crucial role in maintaining genomic stability. Elevated levels of FEN1 activity are closely associated with the development of various cancers, making FEN1 a recognized biomarker and drug target for lung, breast, and prostate cancers. Conventional radioisotope tagging methods for detecting FEN1 nuclease activity present challenges in terms of convenience and safety. In this study, a DNA fragment substrate with a flap structure was synthesized in vitro. This substrate is labeled with a fluorophore at the 5' end of the flap, allowing the FEN1 nuclease to specifically recognize and cleave the designated site. FEN1 activity was then determined by detecting the fluorophore signal after gel electrophoresis. This method enables rapid and effective assessment of FEN1 nuclease activity and the screening of its inhibitors. It provides a sensitive and specific approach for analyzing FEN1 activity and evaluating the efficacy of small-molecule inhibitors. Furthermore, it contributes significantly to research on DNA damage repair and cancer development, offering a novel strategy for clinical research on disease mechanisms and the detection of genotoxic substances.

As shown in Figure 2A, the staining reagent binds to protein, causing the protein to appear as a blue band on the gel. The first lane contains the labeled protein used as a molecular weight reference, in which the BSA standard protein band corresponds to a molecular weight of 70 kDa, and the FEN1 nucleic acid protein band corresponds to a molecular weight of 45 kDa. The experimental results showed that the FEN1 nuclease appeared as a clear band at approximately 45 kDa, indicating successful ...

This protocol describes a gel shift biochemical assay for measuring FEN1 (Flap Endonuclease 1) activity and inhibitor development.

FEN1 (Flap Endonuclease 1) is a key DNA nuclease involved in DNA replication and damage repair, playing a crucial role in maintaining genomic stability. ...

fluorescence-based-detection-fen1-nuclease-activity-screening-small

Research

JoVE Journal

Biology

A novel method involving quantitative analysis of FRET (Förster Resonance Energy Transfer) signals is described for studying enzyme kinetics. KM and kcat were obtained for the hydrolysis of the catalytic domain of SENP1 (SUMO/Sentrin specific protease 1) to pre-SUMO1 (Small Ubiquitin-like MOdifier). The general principles of this quantitative-FRET-based protease kinetic study can be applied to other proteases.

Quantitative FRET (F&#246;rster Resonance Energy Transfer) Analysis for SENP1 Protease Kinetics Determination

Exonucleases play critical roles in ensuring genome stability. Loss of WRN exonuclease function results in premature aging. Studying substrates and other requirements of the nuclease in vitro can help elucidate its role in vivo. Here we demonstrate a rapid and reproducible fluorescence-based assay to measure its nuclease activity.

A Fluorescence-based Exonuclease Assay to Characterize DmWRNexo, Orthologue of Human Progeroid WRN Exonuclease, and Its Application to Other Nucleases

This work presents a method of high-throughput screening using a universal genetic enzyme screening system that can be theoretically applied to over 200 enzymes. Here, the single screening system identifies three different enzymes (lipase, cellulase, and alkaline phosphatase) by simply changing the substrate used (p-nitrophenyl acetate, p-nitrophenyl-β-D-cellobioside, and phenyl phosphate).

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

We present an open source high content analysis (HCA) instrument utilizing automated fluorescence lifetime imaging (FLIM) for assaying protein interactions using Förster resonance energy transfer (FRET) based readouts. Data acquisition for this openFLIM-HCA instrument is controlled by software written in µManager and data analysis is undertaken in FLIMfit.

Open Source High Content Analysis Utilizing Automated Fluorescence Lifetime Imaging Microscopy

NMR-based activity assays have been developed to identify and characterize inhibitors of two nucleoside ribohydrolase enzymes. Protocols are provided for initial compound assays at 500 μM and 250 μM, dose-response assays for determining IC50 values, detergent counter screen assays, jump-dilution counter screen assays, and assays in E. coli whole cells.

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Altered nuclease activity has been associated with different human conditions, underlying its potential as a biomarker. The modular and easy to implement screening methodology presented in this paper allows the selection of specific nucleic acid probes for harnessing nuclease activity as a biomarker of disease.

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Monitoring changes in the melting temperature of a target protein (i.e., thermal shift assay, TSA) is an efficient method for screening fragment libraries of a few hundred compounds. We present a TSA protocol implementing robotics-assisted nano-Differential Scanning Fluorimetry (nano-DSF) for monitoring intrinsic tryptophan fluorescence and light back-scattering for fragment screening.

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

DNA methyltransferases are potential cancer drug targets. Here, a protocol is presented to assess small molecules for DNA methyltransferase inhibition. This assay utilizes an endonuclease to couple DNA methylation to fluorescence generation and allows for enzyme activity to be monitored in real...

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

RASopathies are multisystem genetic syndromes caused by RAS-MAPK pathway hyperactivation. Potentially pathogenic variants awaiting validation emerge continuously while poor preclinical evidence limits therapy. Here, we describe our in vivo protocol to test and cross-validate RASopathy-associated ERK activation levels and its pharmacological modulation during embryogenesis by live FRET imaging in Teen-reporter zebrafish.

An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence

This protocol introduces a fluorometric screening methodology optimized for identifying natural product/small molecule inhibitors of protein synthesis. Its practicality makes it suitable for both undergraduate instruction in drug discovery techniques and implementation in medicinal chemistry campaigns.

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Here, we describe a method for cell-based visualization, subcellular localization, and quantitative analysis of poly(ADP-ribose) (PAR) enriched foci in fixed mammalian cells. This assay enables the quantification of sites of DNA damage-induced PARP activation, including that associated with base excision repair or single-strand break repair, in the nuclei of genotoxin-exposed cells.

Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter

Learn a fluorescence-based assay to detect FEN1 nuclease activity and screen small-molecule inhibitors for cancer therapy research. This method offers a safer, efficient alternative to traditional techniques.

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Explore More Videos